Thrombocytopenia and management of anticoagulation in the patient with thrombosis and cancer
Cancer-associated thrombosis (CAT) presents a unique and multifaceted challenge in clinical practice, particularly in...
AUTHORS
ICTHIC Editorial Office
ICTHIC Editorial Office is based in Milan, Italy, c/o Polistudium srl.
Sara di Nunzio, Italy, Managing Editor
Aashni Shah, UK, Editor
Francesca Cappellini, Italy, Medical Writer and Social Media Manager
Massimiliano Pianta, Italy, Graphic Designer
Giorgio Maitti, IT Developer
Phone +39 3714686513
email: editorialoffice@magazine.icthic.com
Sara di Nunzio, Italy, Managing Editor
Aashni Shah, UK, Editor
Francesca Cappellini, Italy, Medical Writer and Social Media Manager
Massimiliano Pianta, Italy, Graphic Designer
Giorgio Maitti, IT Developer
Phone +39 3714686513
email: editorialoffice@magazine.icthic.com
Managing bleeding in cancer: from anticoagulants to artificial intelligence
Our speakers, Mari Thomas and Miren Taberna, shared some recent updates on the management of bleeding in...
RECORDINGS ONLINE: Managing bleeding in cancer: from anticoagulants to artificial intelligence
In this webinar, Mari Thomas and Miren Taberna shared recent updates on the management of anticoagulation and bleeding...
The Combined Impact of Serum Albumin and Genetic Risk on VTE: Implications for Early Prevention
Venous thromboembolism (VTE), encompassing deep vein thrombosis (DVT) and pulmonary embolism (PE), is the third most...
Heparin-Induced Thrombocytopenia: The Expanding Role of Factor Xa Inhibitors in Therapy
Heparin products, such as unfractionated heparin and low-molecular-weight heparin (LMWH), are commonly employed as...
An Overview of VTE Prevention and Management in Gynecological Cancer Care
As with cancers in general, gynecological cancers also exhibit a clear and increasingly significant association with...
Thromboprophylaxis in Portuguese Cancer Outpatients: Real-World Insights and Patient Characterization
Venous thromboembolism (VTE) affects up to 20% of cancer patients, presenting a four-to-seven-fold increased risk...
Prophylaxis of VTE in the colorectal cancer patient
Colorectal cancer (CRC) is the third most common cancer worldwide and the most prevalent tumor in Western countries,...
Treatment of VTE in the colorectal cancer patient
In clinical practice, cancer-associated thrombosis (CAT) is a frequent phenomenon among colorectal cancer (CRC)...
PROGRAM AVAILABLE: 32nd Congress of the International Society on Thrombosis and Haemostasis (ISTH)
Program available for the 32nd Congress of the International Society on Thrombosis and Haemostasis (ISTH), Bangkok,...